CompletedNot Applicable

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Germany80 participantsStarted 2015-01-01

Plain-language summary

Retrospective monocentric registry to evaluate the efficacy and safety of different anticoagulants in patients with thromboembolic antiphospholipid syndrome

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Minimum age of 18 years * Confirmed antiphospholipid syndrome with thromboembolic clinical manifestations (VTE, LAE, stroke etc.) * Patients with APS antibody risk profile (single/double/triple positivity) Exclusion Criteria: * APS with isolated pregnancy complications * No coagulation inhibition * Inadequately diagnosed APS * Non-compliance of patients

What they're measuring

Recurrent thromboembolism despite coagulation inhibition

Timeframe: 2015 - 2021

Trial details

NCT IDNCT05195372

SponsorCardioangiologisches Centrum Bethanien

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04

View on ClinicalTrials.gov More Antiphospholipid Syndrome trials